ES8106722A1 - Phthalimidine derivatives and pharmaceutical compositions containing them. - Google Patents

Phthalimidine derivatives and pharmaceutical compositions containing them.

Info

Publication number
ES8106722A1
ES8106722A1 ES494506A ES494506A ES8106722A1 ES 8106722 A1 ES8106722 A1 ES 8106722A1 ES 494506 A ES494506 A ES 494506A ES 494506 A ES494506 A ES 494506A ES 8106722 A1 ES8106722 A1 ES 8106722A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
compositions containing
carbon atoms
phthalimidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES494506A
Other languages
Spanish (es)
Other versions
ES494506A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of ES494506A0 publication Critical patent/ES494506A0/en
Publication of ES8106722A1 publication Critical patent/ES8106722A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4

Abstract

Compounds having antipsychotic activity, characterized by the formula < IMAGE > in which formula Ro and R1 are the same or different and are each selected from hydrogen, halogen, alkyl having 1, 2 or 3 carbon atoms, alkoxy having 1, 2 or 3 carbon atoms, and trifluoromethyl, and R2 is selected from hydrogen, halogen, alkyl having 1, 2 or 3 carbon atoms, alkoxy having 1, 2 or 3 carbon atoms, and trifluoromethyl, pharmaceutical compositions containing them, and a method for the treatment of psychoses.
ES494506A 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them. Expired ES8106722A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7907121A SE7907121L (en) 1979-08-27 1979-08-27 FTALIMIDINDERIVAT

Publications (2)

Publication Number Publication Date
ES494506A0 ES494506A0 (en) 1981-08-01
ES8106722A1 true ES8106722A1 (en) 1981-08-01

Family

ID=20338703

Family Applications (6)

Application Number Title Priority Date Filing Date
ES494508A Expired ES8106723A1 (en) 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them.
ES494505A Granted ES494505A0 (en) 1979-08-27 1980-08-26 A METHOD FOR THE PREPARATION OF PHTHALIMIDINE DERIVATIVES
ES494502A Expired ES8103743A1 (en) 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them.
ES494504A Expired ES8103744A1 (en) 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them.
ES494507A Expired ES8104275A1 (en) 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them.
ES494506A Expired ES8106722A1 (en) 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them.

Family Applications Before (5)

Application Number Title Priority Date Filing Date
ES494508A Expired ES8106723A1 (en) 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them.
ES494505A Granted ES494505A0 (en) 1979-08-27 1980-08-26 A METHOD FOR THE PREPARATION OF PHTHALIMIDINE DERIVATIVES
ES494502A Expired ES8103743A1 (en) 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them.
ES494504A Expired ES8103744A1 (en) 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them.
ES494507A Expired ES8104275A1 (en) 1979-08-27 1980-08-26 Phthalimidine derivatives and pharmaceutical compositions containing them.

Country Status (12)

Country Link
US (1) US4289781A (en)
EP (1) EP0026749A1 (en)
JP (1) JPS5634679A (en)
AU (1) AU6151380A (en)
DK (1) DK365280A (en)
ES (6) ES8106723A1 (en)
FI (1) FI802686A (en)
IL (1) IL60478A0 (en)
NO (1) NO802215L (en)
SE (1) SE7907121L (en)
SU (1) SU969164A3 (en)
ZA (1) ZA804057B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1169078A (en) * 1980-12-29 1984-06-12 Michael J. Fifolt Method for the preparation of fluorophthalamic compounds
ZA83508B (en) * 1982-01-27 1983-10-26 Britax Wingard Ltd Ferrule attachment
EP0093488A3 (en) * 1982-03-18 1984-05-23 Beecham Group Plc Nortropyl benzopyrrolinone compounds, process for their preparation and pharmaceutical compositions containing them
US4600758A (en) * 1982-11-12 1986-07-15 Mead Johnson & Company Isoindole derivatives
US4495194A (en) * 1982-11-12 1985-01-22 Mead Johnson & Company Antihypertensive isoindole derivatives
US4505911A (en) * 1983-10-13 1985-03-19 Mead Johnson & Company Isoindole diuretic derivatives, compositions and use
US4585773A (en) * 1984-07-11 1986-04-29 Bristol-Myers Company Isoindolinyl-alkyl-piperazines
JPS6169773A (en) * 1984-09-14 1986-04-10 Takeda Chem Ind Ltd Isoindolinone derivative
FI95572C (en) * 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt
EP0351283A1 (en) * 1988-07-12 1990-01-17 Synthelabo 2-[(4-Piperidinyl)methyl]-2,3-dihydro-1H-isoindole and 2,3,4,5-tetrahydro-1H-benzazepine derivatives, their preparation and therapeutical use
US5028616A (en) * 1989-09-05 1991-07-02 G. D. Searle & Co. N-benzylpiperidine amides
US5210090A (en) * 1989-09-05 1993-05-11 G. D. Searle & Co. Substituted N-benzylpiperidine amides and cardiac regulatory compositions thereof
US5098915A (en) * 1989-09-05 1992-03-24 G. D. Searle & Co. Substituted N-benzylpiperidine amides
US5053413A (en) * 1989-09-05 1991-10-01 G. D. Searle & Co. N-benzylpiperidineisoindolinones
US5070094A (en) * 1989-09-05 1991-12-03 G. D. Searle & Co. N-benzyltropaneamides
US4992446A (en) * 1989-09-05 1991-02-12 G. D. Searle & Co. Tricyclic quinolizine amides
US5356906A (en) * 1989-10-27 1994-10-18 The Du Pont Merck Pharmaceutical Company (N-phthalimidoalkyl) piperidines useful as treatments for psychosis
CA2069318A1 (en) * 1989-10-27 1991-04-28 Engelbert Ciganek (n-phthalimidoalkyl) piperidines
JP2807577B2 (en) * 1990-06-15 1998-10-08 エーザイ株式会社 Cyclic amide derivative
US5162341A (en) * 1991-02-22 1992-11-10 Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists for treatment of amphetamine abuse
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5567718A (en) * 1994-08-11 1996-10-22 Hoechst Marion Roussel Inc. 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors
US5827875A (en) * 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5885983A (en) * 1996-05-10 1999-03-23 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
US5760246A (en) 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
WO2000000472A1 (en) * 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company 5-ht7 receptor antagonists
FI20021421A0 (en) * 2002-07-30 2002-07-30 Orion Corp Fermion Production Process
US6881815B2 (en) * 2002-09-25 2005-04-19 General Electric Company Method for the preparation poly(etherimide)s
TW200918062A (en) * 2007-09-12 2009-05-01 Wyeth Corp Azacyclylisoquinolinone and-isoindolinone derivatives as histamine-3 antagonists
US8278302B2 (en) * 2009-04-08 2012-10-02 Boehringer Ingelheim International Gmbh Substituted piperidines as CCR3 antagonists
UA109290C2 (en) 2010-10-07 2015-08-10 Common Crystals and Salts of CCR3 Inhibitors
AR090566A1 (en) 2012-04-02 2014-11-19 Boehringer Ingelheim Int PROCESS FOR THE PRODUCTION OF CRR INHIBITORS
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34317A0 (en) 1969-04-23 1970-06-17 Kabi Ab Substituted acetamides,their preparation and pharmaceutical compositions containing them
SE333734B (en) 1969-04-23 1971-03-29 Kabi Ab
US4053615A (en) * 1972-10-21 1977-10-11 John Wyeth & Brother Limited Phthalimidopiperidines and anti-convulsant compositions thereof
GB1425578A (en) * 1972-10-21 1976-02-18 Wyeth John & Brother Ltd Piperidine derivatives
GB1486104A (en) 1975-01-23 1977-09-21 Wyeth John & Brother Ltd Phthalimidopiperidine derivatives
US4000287A (en) * 1974-12-16 1976-12-28 Ciba-Geigy Corporation Isoindolinopiperidines

Also Published As

Publication number Publication date
ES8106721A1 (en) 1981-08-01
AU6151380A (en) 1981-03-05
ES494508A0 (en) 1981-08-01
ES494507A0 (en) 1981-04-01
ES494506A0 (en) 1981-08-01
ES494502A0 (en) 1981-03-16
SE7907121L (en) 1981-02-28
ES494504A0 (en) 1981-03-16
IL60478A0 (en) 1980-09-16
JPS5634679A (en) 1981-04-06
DK365280A (en) 1981-02-28
SU969164A3 (en) 1982-10-23
ES8104275A1 (en) 1981-04-01
ES494505A0 (en) 1981-08-01
EP0026749A1 (en) 1981-04-08
US4289781A (en) 1981-09-15
ES8106723A1 (en) 1981-08-01
FI802686A (en) 1981-02-28
NO802215L (en) 1981-03-02
ES8103743A1 (en) 1981-03-16
ZA804057B (en) 1981-07-29
ES8103744A1 (en) 1981-03-16

Similar Documents

Publication Publication Date Title
ES8103743A1 (en) Phthalimidine derivatives and pharmaceutical compositions containing them.
ES8301962A1 (en) Carbostyril derivatives and pharmaceutical composition containing the same
IL67812A (en) Indanylbenzamide derivatives,process for the preparation thereof and fungicidal compositions comprising the same
DE3160360D1 (en) 5-subsituted 5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-ones, process for preparing them and medicaments containing them
ES8203867A1 (en) Benzothiazole derivatives, pharmaceutical compositions containing them and process for their preparation.
ES8202818A1 (en) Tetrazolylcoumarin derivatives, process for preparing the same and composition containing the same.
DE3465082D1 (en) Pyridazinone derivatives, process for their preparation and their use as fungicides
DE3069173D1 (en) Substituted phenylamino-2-imidazoline-2 derivatives, their acid addition salts, medicaments containing them and process for their preparation
ES8103081A1 (en) Polysubstituted diazatricyclic derivatives, processes for their preparation and pharmaceutical compositions containing them.
ES8801637A1 (en) Derivatives of 2-fluoroalkylbenzimidazole, process for their preparation and pharmaceutical compositions containing them.
ES8600224A1 (en) Carbamyloxybenzhydrole derivatives, process for their preparation and pharmaceutical compositions containing them.
DE3167347D1 (en) New benzothiazine derivatives, processes for preparation thereof and use thereof
DE3365933D1 (en) Substituted thienobenzodiazepinones, process for their preparation and medicines containing these compounds
GB2004885A (en) Indolopyrones
HUT38948A (en) Process for preparing new isoxazolo-quinolinone derivatives and pharmaceutical compositions containing such compounds
IL70558A (en) 1-(aminoalkoxyphenyl)-1-phenylpropanols,their preparation and pharmaceutical compositions containing them
ES8501757A1 (en) Imidazobenzodiazepines, process for their preparation, pharmaceutical preparations containing these compounds and their therapeutical use.
ES8307798A1 (en) 1,2,3,4,4a,9b-Hexahydro-4a-piperazinylmethyl-4-dibenzofuranones or substituted 4-dibenzofuranoles, process for their preparation and their therapeutic use.
ATE53839T1 (en) 2,3-DIHYDRO-3-PHENYL-BENZOFURAN-2-ONACETAMIDE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICALS CONTAINING THEM.
CA1246075A (en) Aminoalkoxybenzopyranones as antipsychotic agents
CH653840GA3 (en) Process for protecting keratin-containing materials from attack by keratin-eating insects and 5-phenylcarbamoylbarbituric acid compounds
DE3361834D1 (en) Dithiino (1,4) (2,3-c) pyrrole derivatives, their preparation and pharmaceutical compositions containing them
ES8300752A1 (en) Process for the preparation of N-phthalidyl-5- fluorouracil derivatives